School of Medicine

Showing 1-10 of 13 Results

Current Role at Stanford
David coordinates web content publishing for the library. He monitors usage and user patterns, gathers feedback, performs diverse and ongoing forms of usability testing and research.

Bio
Christopher Thomas Scott, MLA, PhD, is Director of the Stanford University Program on Stem Cells in Society, a faculty and senior research scholar at the Stanford Center for Biomedical Ethics, and a member of the Stanford Institute for Stem Cell Biology and Regenerative Medicine. He is part of the University of British Columbia’s National Core on Neuroethics. His academic interests focus on the social, economic, political and ethical dimensions of new biotechnologies. Scott is widely published in high impact journals such as Cell, Cell Stem Cell, Nature Methods, Nature Biotechnology, and the American Journal of Bioethics. His introductory text on stem cell biology, Stem Cell Now (Penguin/Plume) has been translated into four languages. He has taught stem cell biology to undergraduates and directs three Stanford courses on the ethics, policy and law of stem cell research. He is a contributing editor at Nature Biotechnology and serves on the editorial boards of several journals. A former cell biologist, Scott was the Assistant Vice Chancellor at the University of California, San Francisco (UCSF), and co-founded Acumen Sciences, a research and consulting company based in San Francisco. He was past President and CEO of The Stem Cell Advisors, a non-profit company providing stem cell research oversight for biotechnology companies. He is one of only a handful of senior officials awarded for their contributions to Stanford’s research enterprise. He is regularly featured in national and local coverage of ethics and policy, including ABC, BBC, NBC, PBS, The New York Times, The Boston Globe, Time, U.S. News and World Report, Boston Globe, The Atlantic Monthly, Nightline, UPI, Fox, and NPR’s Fresh Air with Terry Gross, Talk of the Nation, and TechNation.

Current Research and Scholarly Interests
My research focuses on the molecular mechanisms driving cardiovascular development, disease, and regeneration. I am interested in basic cardiomyocyte biology, utilizing induced pluripotent stem cells for the in-vitro modeling of cardiovascular disorders, and using stem cell-derived cardiomyocytes for high-throughput drug screening/discovery.